XML 100 R69.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Numerator:        
Net income attributable to Biogen Inc. $ 329.2 $ 701.5 $ 1,187.9 $ 3,642.7
Weighted-average shares used in calculating:        
Weighted average number of common shares outstanding 148.0 156.9 149.9 163.4
Effect of dilutive securities:        
Dilutive potential common shares 0.6 0.3 0.4 0.3
Shares used in calculating diluted earnings per share 148.6 157.2 150.3 163.7
Time-vested restricted stock units        
Effect of dilutive securities:        
Stock units 0.4 0.1 0.2 0.1
Market stock units        
Effect of dilutive securities:        
Stock units 0.1 0.1 0.1 0.1
Performance stock units settled in stock        
Effect of dilutive securities:        
Stock units 0.1 0.1 0.1 0.1